Theriva Biologics Stock Price Patterns
| TOVX Stock | USD 0.18 0.03 14.29% |
Momentum 41
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.37) | EPS Estimate Current Year (2.15) | EPS Estimate Next Year (0.75) | Wall Street Target Price 7 | EPS Estimate Current Quarter (0.38) |
Using Theriva Biologics hype-based prediction, you can estimate the value of Theriva Biologics from the perspective of Theriva Biologics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Theriva Biologics to buy its stock at a price that has no basis in reality. In that case, they are not buying Theriva because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Theriva Biologics after-hype prediction price | USD 0.18 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Theriva Biologics Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Theriva Biologics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Theriva Biologics After-Hype Price Density Analysis
As far as predicting the price of Theriva Biologics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Theriva Biologics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Theriva Biologics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Theriva Biologics Estimiated After-Hype Price Volatility
In the context of predicting Theriva Biologics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Theriva Biologics' historical news coverage. Theriva Biologics' after-hype downside and upside margins for the prediction period are 0.01 and 7.91, respectively. We have considered Theriva Biologics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Theriva Biologics is out of control at this time. Analysis and calculation of next after-hype price of Theriva Biologics is based on 3 months time horizon.
Theriva Biologics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Theriva Biologics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Theriva Biologics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Theriva Biologics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.18 | 7.72 | 0.00 | 0.07 | 10 Events / Month | 5 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.18 | 0.18 | 0.00 |
|
Theriva Biologics Hype Timeline
Theriva Biologics is at this time traded for 0.18. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.07. Theriva is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is at this time at -0.18%. %. The volatility of related hype on Theriva Biologics is about 1916.58%, with the expected price after the next announcement by competition of 0.11. The company has price-to-book ratio of 0.96. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Theriva Biologics last dividend was issued on the 13th of August 2018. The entity had 1:25 split on the 26th of August 2024. Given the investment horizon of 90 days the next anticipated press release will be in about 10 days. Check out Theriva Biologics Basic Forecasting Models to cross-verify your projections.Theriva Biologics Related Hype Analysis
Having access to credible news sources related to Theriva Biologics' direct competition is more important than ever and may enhance your ability to predict Theriva Biologics' future price movements. Getting to know how Theriva Biologics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Theriva Biologics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GLMD | Galmed Pharmaceuticals | 0.02 | 6 per month | 0.00 | (0.18) | 9.33 | (8.96) | 21.39 | |
| BIVI | Biovie Inc | (0.03) | 9 per month | 0.00 | (0.06) | 8.16 | (7.45) | 23.28 | |
| NKGN | NKGen Biotech Common | (0.15) | 20 per month | 0.00 | 0.21 | 20.00 | (6.00) | 68.90 | |
| ELAB | Elevai Labs Common | (3.88) | 5 per month | 0.00 | (0.42) | 7.40 | (20.40) | 53.38 | |
| MLEC | Moolec Science SA | 0.28 | 9 per month | 10.34 | 0.06 | 19.46 | (17.38) | 152.55 | |
| ISPC | iSpecimen | 0.02 | 10 per month | 0.00 | (0.12) | 11.54 | (11.76) | 37.80 | |
| WINT | Windtree Therapeutics | 0.00 | 4 per month | 0.00 | (0.20) | 16.67 | (20.00) | 75.00 | |
| BCTXZ | BriaCell Therapeutics Corp | 0.03 | 5 per month | 0.00 | (0.07) | 18.52 | (22.22) | 69.68 | |
| CMMB | Chemomab Therapeutics Ltd | (0.32) | 4 per month | 0.00 | (0.19) | 7.74 | (7.21) | 21.53 | |
| CARM | Carisma Therapeutics | 0 | 4 per month | 8.88 | 0.04 | 17.95 | (14.06) | 56.42 |
Theriva Biologics Additional Predictive Modules
Most predictive techniques to examine Theriva price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Theriva using various technical indicators. When you analyze Theriva charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Theriva Biologics Predictive Indicators
The successful prediction of Theriva Biologics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Theriva Biologics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Theriva Biologics based on analysis of Theriva Biologics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Theriva Biologics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Theriva Biologics's related companies. | 2023 | 2024 (projected) | Net Debt To EBITDA | 0.96 | 0.52 | Intangibles To Total Assets | 0.46 | 0.49 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Theriva Stock Analysis
When running Theriva Biologics' price analysis, check to measure Theriva Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theriva Biologics is operating at the current time. Most of Theriva Biologics' value examination focuses on studying past and present price action to predict the probability of Theriva Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theriva Biologics' price. Additionally, you may evaluate how the addition of Theriva Biologics to your portfolios can decrease your overall portfolio volatility.